Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04053036 · ClinicalTrials.gov registry record · Early Phase 1

Effects of Drugs on Responses to Brain and Emotional Processes

A Early Phase 1 study of Healthy and Autism Spectrum Disorder, sponsored by University of Chicago.

Completed
Registry status
Early Phase 1
Development phase
22
Enrollment target
1
Study location

NCT04053036 is a Early Phase 1 study of Healthy and Autism Spectrum Disorder that has completed, run by University of Chicago. The registered enrollment target is 22 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04053036, a Early Phase 1 study of Healthy and Autism Spectrum Disorder, has completed, sponsored by University of Chicago.

COMPLETED
Registry status
Early Phase 1
Development phase
22 participants
Enrollment target
1
Study location

Study Summary

To study the effects of a psychostimulant on responses to affective touch in individuals with a range of autistic traits

Conditions Studied

Healthy Autism Spectrum Disorder

Interventions

  • DRUG Placebo oral tablet
  • DRUG MDMA

Study Locations (1)

Illinois

  • University of Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2019-08-08
Est. Completion 2021-04-12
Phase Early Phase 1

Sponsor

University of Chicago

796 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04053036

The ClinicalTrials.gov registry entry for NCT04053036 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (97% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Placebo oral tablet is the first listed.

NCT04053036 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT04053036 about?

NCT04053036 is a clinical study titled "Effects of Drugs on Responses to Brain and Emotional Processes". To study the effects of a psychostimulant on responses to affective touch in individuals with a range of autistic traits

What is the current status of trial NCT04053036?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 22 participants. The study started on 2019-08-08. Estimated completion is 2021-04-12.

What conditions does trial NCT04053036 study?

This clinical trial studies the following conditions: Healthy, Autism Spectrum Disorder.

What interventions are being tested in trial NCT04053036?

The interventions under investigation include: Placebo oral tablet (DRUG), MDMA (DRUG).

Who is sponsoring clinical trial NCT04053036?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04053036 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Healthy

All registered trials for this condition

Autism Spectrum Disorder

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.